Loading...
Dernières publications
-
Francesco Galli, Laricia Bragg, Maira Rossi, Daisy Proietti, Laura Perani, et al.. Cell-mediated exon skipping normalizes dystrophin expression and muscle function in a new mouse model of Duchenne Muscular Dystrophy. EMBO Molecular Medicine, 2024, 16 (4), pp.927 - 944. ⟨10.1038/s44321-024-00031-3⟩. ⟨hal-04603972⟩
-
Ekaterina Kiseleva, Olesya Serbina, Anna Karpukhina, Vincent Mouly, Yegor S Vassetzky. Interaction between mesenchymal stem cells and myoblasts in the context of facioscapulohumeral muscular dystrophy contributes to the disease phenotype. Journal of Cellular Physiology, 2022, 237 (8), pp.3328-3337. ⟨10.1002/jcp.30789⟩. ⟨hal-03796151⟩
-
Muhammad Haseeb Iqbal, Jeanne Rosine Faratiana, Emeline Pradel, Varvara Gribova, Kamel Mamchaoui, et al.. Brush-Induced Orientation of Collagen Fibers in Layer-by-Layer Nanofilms: A Simple Method for the Development of Human Muscle Fibers. ACS Nano, In press, ⟨10.1021/acsnano.2c06329⟩. ⟨hal-03832239⟩
Chiffres clés
Open Access
87 %
Mots clés
Glucocorticoid-induced muscle atrophy
Exon-skipping
DsDNA break repair
Skeletal muscle
Folding-defective proteins
Bioinformatics
Antisense morpholino
Genetics
LTβR
Drisapersen
ICU-acquired weakness
Myogenesis
Fibroblast
Exon skipping
Bile acid
Immortalisation
Allele-specific silencing
Myotube
RNA interference
Autophagy
BMD
DNM2
CXCR4
CFTR correctors
CLS
Dominant centronuclear myopathy
Neuromuscular disease
Coculture
3D co-culture
CXCL12
Myotonic dystrophy
Endocytosis
Becker muscular dystrophy
Cell biology
Exondys 51
Expanded repeats
KLF15
Flavonoid
Immortalized dystrophic canine myoblast
DMD
Lamin A/C nuclei
Autophagosome
Eteplirsen
Duchenne muscular dystrophy
Culture platform
Conjugation
DiPRO1
HDMD/Dmd-null mice
Laminographie
Alternative splicing
Computer software
Developmental biology
Lamina-associated domain
CMS
ITSN1
Human
CDNA synthesis
Gel electrophoresis
Migration
Gene network analysis
Clinical trial candidate screening
Exon Skipping
Duchenne Muscular Dystrophy
Chromatin
DM1 myoblasts
Atrial cardiac defects
Muscle
Insulin
BAF
FSHD
Emerin
Canine X-linked muscular dystrophy in Japan CXMD J
Cell Therapy
Motor neuron
Gut microbiota
Antisense oligonucleotide
Actin
Dynamin 2
Cell-penetrating peptide
Dystrophin
CTG⋅CAGn repeat
Centronuclear myopathy
CRISPR/Cas9
Gene Therapy
FoxO
Glucose
Fibrosis
Fear response
Human muscle stem/progenitor cells
Acetylcholine receptor subunit epsilon
Human artificial chromosomes
Gene therapy
Neuromuscular junction
Adhesion
Allele-specific silencing therapy
Becker muscular dystrophy BMD Duchenne muscular dystrophy DMD miRNA nNOS
LRP4
Adeno-associated viral vector
Biomimetism
Differentiation